This webinar has already passed. You can view the recording here.


  • Josephine Mauskopf, PhD
  • Baudouin Standaert, MD, PhD
  • Mark P. Connolly, PhD
  • Mark Jit, BSc, MPh, PhD
  • Louis P. Garrison, Jr., PhD
  • Raymond Hutubessy, PhD
  • Paul Revill, MSc
  • Johan L. Severens, PhD

From the perspectives of various decision makers, a recent ISPOR Task Force has provided guidelines for those using cost-effectiveness analysis, constrained optimization, or fiscal health modeling in the evaluation of vaccination programs. This webinar will first describe why multiple methods are proposed. It will then highlight the key recommendations for each method as presented in the ISPOR report. Due to recent updates within the World Health Organization guidelines on evaluation of vaccination programs, the webinar will also present highlights from their new guidelines. The webinar includes expected future developments in the evaluation of vaccination programs. There will be an opportunity to pose questions at the end of the webinar.


Participants will gain the following insights & understanding:

  • Economic evaluation methods may need to vary with the decision maker’s objective and their operational context;
  • Evaluation methods can be summarized using the following 4 main topics: decision description, modeling approach, data evaluation, and logistics for doing the analysis;
  • Economic recommendations of the ISPOR Task Force and the World Health Organization on cost-effectiveness analysis are equivalent or compatible;
  • Recommendations of the ISPOR Task Force on constrained optimization and fiscal health modeling provide guidelines for alternative approaches to economic evaluation of vaccination programs;
  • Future development in the economic assessment of vaccines will include their impact beyond health care for cases avoided.

This webinar is open to All ISPOR Members and Non-members.


Josephine Mauskopf, PhD
Vice President, Health Economics
RTI Health Solutions
Research Triangle Park, NC, USA

Baudouin Standaert, MD, PhD
Senior Director, Lead of Health Economics
GSK Vaccines
Wavre, Belgium


Mark P. Connolly, PhD
Senior Research Scientist
Department of Pharmacy
University of Groningen
Groningen, The Netherlands& Global Market Access Solutions LLC
Geneva, Switzerland

Mark Jit, BSc, MPh, PhD
Professor of Vaccine Epidemiology
Department of Infectious Disease Epidemiology
London School of Hygiene & Tropical Medicine and Public Health
London, UK

Louis P. Garrison, Jr., PhD
Professor Emeritus
The Comparative Health Outcomes, Policy, and Economics Institute
University of Washington
Seattle, WA, USA

Raymond Hutubessy, PhD
Senior Vaccine Economist
World Health Organization
Geneva, Switzerland

Paul Revill, MSc
Senior Research Fellow
Centre for Health Economics
University of York, York, UK

Baudouin Standaert, MD, PhD
Senior Director, Lead of Health Economics
GSK Vaccines
Wavre, Belgium

Johan L. Severens, PhD
Dean & Professor, Evaluation in Health Care
ESHPM & the Institute of Medical Technology Assessment
Erasmus University Rotterdam
Rotterdam, The Netherlands

Please note: On the day of the scheduled webinar, the first 500 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later date, the full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 weeks after the scheduled Webinar.

Reservations are on a first-come, first-served basis for all ISPOR members.

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now